SCHEMBL11385606

SCHEMBL11385606

C=CCCC(=O)/C=C/C1=C(C)CCCC1(C)C

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HAO1 Q9UJM8 1/20 0.65
▸ CYP1A2 P05177 2/20 0.62
▸ ALDH1A1 P00352 9/20 0.50
▸ RXRA P19793 6/20 0.50
▸ RARA P10276 6/20 0.50
▸ RARB P10826 6/20 0.50
▸ RARG P13631 6/20 0.50
▸ MAPT P10636 6/20 0.50
▸ CYP3A4 P08684 5/20 0.50
▸ PTGS1 P23219 4/20 0.50
▸ RXRB P28702 2/20 0.50
▸ RXRG P48443 2/20 0.50
▸ RORC P51449 2/20 0.50
▸ ADORA3 P0DMS8 2/20 0.50
▸ MAPK1 P28482 2/20 0.50
▸ DRD3 P35462 2/20 0.50
▸ HTR2B P41595 2/20 0.50
▸ BLM P54132 2/20 0.50
▸ HIF1A Q16665 2/20 0.50
▸ LMNA P02545 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11385629 1.00 HAO1 (0.65) HAO1CYP1A2ALDH1A1RXRARARA
SCHEMBL29012640 0.90 HAO1 (0.74) HAO1CYP1A2ALDH1A1RXRARARA
SCHEMBL1275512 0.86 HAO1 (0.68) HAO1CYP1A2ALDH1A1RXRARARA
SCHEMBL1275491 0.86 HAO1 (0.68) HAO1CYP1A2ALDH1A1RXRARARA
SCHEMBL1761126 0.85 HAO1 (0.86) HAO1CYP1A2ALDH1A1RXRARARA
SCHEMBL2130233 0.82 HAO1 (0.72) HAO1CYP1A2ALDH1A1RXRARARA
SCHEMBL1404273 0.82 HAO1 (0.72) HAO1CYP1A2ALDH1A1RXRARARA
SCHEMBL2347199 0.82 HAO1 (0.72) HAO1CYP1A2ALDH1A1RXRARARA
SCHEMBL28602034 0.82 HAO1 (0.72) HAO1CYP1A2ALDH1A1RXRARARA
SCHEMBL1404271 0.82 HAO1 (0.72) HAO1CYP1A2ALDH1A1RXRARARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12290591-B2 Fragrance compositions FIRMENICH SA (CH) 2025-05-06 — — US claimed
US-20220096355-A1 FRAGRANCE COMPOSITIONS FIRMENICH SA (CH) 2022-03-31 — — US claimed
CN-113784759-A Fragrance composition 弗门尼舍有限公司 2021-12-10 — — CN claimed
WO-2026087780-A1 CORE-SHELL MICROCAPSULES FIRMENICH SA (CH) 2026-04-30 — — WO disclosed
EP-4713129-A1 ORGANOSILICON-BASED MICROCAPSULES Firmenich SA (CH) 2026-03-25 — — EP disclosed
EP-4711438-A2 PERFUME DELIVERY SYSTEM Firmenich SA (CH) 2026-03-18 — — EP disclosed
EP-4711037-A2 PERFUME FORMULATION FOR DELIVERY SYSTEM Firmenich SA (CH) 2026-03-18 — — EP disclosed
EP-4706627-A2 LAUNDRY COMPOSITION Firmenich SA (CH) 2026-03-11 — — EP disclosed
EP-4077626-B1 LAUNDRY COMPOSITION FIRMENICH & CIE (CH) 2026-02-11 — — EP disclosed
EP-4077625-B1 PERFUME DELIVERY SYSTEM FIRMENICH & CIE (CH) 2026-02-11 — — EP disclosed
EP-4688246-A1 COACERVATE CORE-SHELL MICROCAPSULES Firmenich SA (CH) 2026-02-11 — — EP disclosed
WO-2022136007-A1 PROCESS FOR PREPARING POLYESTER MICROCAPSULES FIRMENICH SA (CH) 2022-06-30 — — WO disclosed
WO-2022136021-A1 PROCESS FOR PREPARING MICROCAPSULES FIRMENICH SA (CH) 2022-06-30 — — WO disclosed
WO-2022136008-A1 PROCESS FOR PREPARING POLYESTER MICROCAPSULES FIRMENICH SA (CH) 2022-06-30 — — WO disclosed
WO-2021122630-A1 PERFUME FORMULATION FOR DELIVERY SYSTEM FIRMENICH SA (CH) 2021-06-24 — — WO disclosed
WO-2021122636-A1 LAUNDRY COMPOSITION FIRMENICH SA (CH) 2021-06-24 — — WO disclosed
WO-2021122633-A1 PERFUME DELIVERY SYSTEM FIRMENICH SA (CH) 2021-06-24 — — WO disclosed
US-20200345601-A1 USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR FIRMENICH SA (CH) 2020-11-05 — — US disclosed
US-20190343977-A1 USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE PERCEPTION OF FECAL MALODOUR FIRMENICH SA (CH) 2019-11-14 — — US disclosed
US-4245122-A USING TRICAPRYLMETHYLAMMONIUM CHLORIDE AS A PHASE TRANSFER AGENT INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1981-01-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200345601-A1 USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR TAS2R8, TRPA1, TAS2R10 HAO1 715/4885CYP1A2 312/4885ALDH1A1 831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback